Please sign in with your existing account details.
Register to access exclusive content, sign up to receive our updates and personalise your experience on brownejacobson.com.
Privacy statement - Terms and conditions
Forgotten your password?
You have exceeded the maximum number of login attempts for this email address and your account has been locked. An email has been sent to member of Browne Jacobson's web team and some one will be contacting you over the next two working days with details of how to change your password.
Are you sure you want to remove this item from you pinned content?
Leaked papers reveal plans by Education Secretary Michael Gove to reform the GCSE exam system. There are two key elements to the proposal; single exam boards to reduce competition leading to easier exams and new “world class qualifications" that give every student the opportunity to "achieve their utmost."
Not only has the timing of the leak being criticised, the second limb of the proposed reforms has prompted outrage from the teaching unions and MPs. Without further details on the proposal it is difficult to see whether the reforms will be a return to the past and create a two-tier system that damages not enhances social mobility. However, there is clearly a risk of this happening.
Hot on the heels of the recent reforms around the primary curriculum there is no doubt that the consultation on these latest reforms will lead to fierce debate as to whether the reforms will take us backwards rather than deliver a qualification system that is amongst the best in the world.
With the Prime Ministers announcement that he intends for Step 4 to begin on 19 July, this will also bring an end to the restrictions currently in place on education settings.
View blog
The issue of Female Genital Mutilation Protection Orders and the importance of education providers to act promptly.
Our top tips for supporting transgender and non-binary pupils.
On 4 June, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the use of the Pfizer/BioNTech Covid-19 vaccine for 12- to 15-year-olds.
Partner
Select which mailings you would like to receive from us.
Sign up